Supplement encyclopedia

CITRULLINE

Citrulline is an amino acid found in the body and in some foods and supplements.

Double-check conclusions and examine the sources before choosing a supplement.

Main conclusion

What it may offer

  • No convincing advantage of citrulline malate was found for additional gains in maximal strength. In a six-week study in trained men, neither L-citrulline nor malate increased maximal strength gains compared with training and placebo.
  • A single dose of 6–8 g citrulline malate may produce a small increase in repetitions: in a review the average was about three additional repetitions, but confidence in this result is low. A separate comparison of single doses of L-citrulline and malate found no clear advantage in repetitions.
  • In one small six-week study in trained men, 8 g of L-citrulline or 12 g of malate daily helped participants perform a few more press repetitions than training with placebo. No convincing additional advantage was established for leg exercises.
  • No convincing endurance advantage was found: in a review of different citrulline sources, participants did not complete a set distance faster and could not clearly continue exercise until exhaustion for longer.
  • Citrulline malate and watermelon products containing citrulline may reduce muscle soreness the day after exercise, but results varied greatly. At 48 and 72 hours the primary analysis found no difference; in a separate study, a single dose of L-citrulline or malate did not reduce pain at either time point.
  • In a small study, trained sprinters took 8 g of citrulline malate between two 100 m runs, with 80–90 minutes of rest. Before the second start, exertion felt easier than after placebo; no convincing difference was found in the time of either run.

[1] [2] [3] [4] [5] [6] [7]

What was studied

  • Studies included healthy adults of different training levels, including trained men and women; strength, repetitions, endurance and post-exercise soreness were studied separately.
  • A single pre-exercise dose and a six-week course alongside training were compared; the sprinter study assessed two runs separated by 80–90 minutes of rest.

[1] [2] [3] [4] [5] [6]

Forms studied

  • When choosing a product, distinguish free L-citrulline from citrulline malate: the weight of the mixture is not the weight of citrulline itself.
  • A six-week study used 8 g of L-citrulline or 12 g of citrulline DL-malate daily alongside training; these are studied regimens, not a universal dose for self-administration.

[1] [2]

Food sources

  • Watermelon is a food source of citrulline: it is present in the flesh and rind, and rind content varies by cultivar.
  • Citrulline is also found in cucumber, pumpkin, melon and bitter melon; these foods can be considered dietary sources, but a food serving cannot be equated to a supplement dose used in a study.

[1]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
maximal strengthIn pooled malate trials, an advantage in maximal strength was not established. Upper- and lower-body estimates are presented as subgroups.SMD 0.13; 95% CI −0.21 to 0.46; lower body 0.06 (−0.47 to 0.60), upper body 0.17 (−0.26 to 0.60)
2/4 LowChappell, Farney, Glenn and Hwang were pooled; for Hwang, whether the 4- or 8-week time point was used in the meta-analysis is not established. Aguiar’s journal table is unavailable; the thesis does not establish that it is identical. Upper and lower body are subgroups, not new studies. Chappell, Farney, Glenn and Hwang are named; the review is not a new trial, and 138 observations should not be counted as 138 unique participants. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 1, imprecision 1, publication bias 0; no upgrades. Low confidence (2) applies only to the stated comparison, does not establish practical significance and is not clinical approval.
11 review of studiesEffects of Citrulline Malate Supplementation on Muscle Strength in Resistance-Trained Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗Trained adults, 4 RCTs, 138 observations across conditions, not necessarily unique individuals
  1. Effects of Citrulline Malate Supplementation on Muscle Strength in Resistance-Trained Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
hack squat 1RMAn additional change in 1RM was not statistically established.Group × time interaction p=0.763. 1RM increased in all groups during training.
3/4 ModerateOver six weeks, an additional increase in hack-squat 1RM compared with placebo was not established, although all groups improved with training. Confidence is moderate: the groups were small, and the absence of a significant difference does not prove that the effects are equal.
11 trialChanges in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo
  1. Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗
bench press 1RMAn additional change in 1RM was not statistically established.Group × time interaction p=0.517. 1RM increased in all groups during training.
3/4 ModerateOver six weeks, an additional increase in bench-press 1RM compared with placebo was not established, although all groups improved with training. Confidence is moderate: the groups were small, and the absence of a significant difference does not prove that the effects are equal.
11 trialChanges in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo
  1. Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextDetails
Intake and studied regimensOn the package distinguish the mass of free L-citrulline from the mass of citrulline malate: 8 g of mixture does not mean 8 g citrulline. In five tested products with a stated 2:1 ratio, actual ratios were 1.11:1–1.92:1.
Repetitions: citrulline malateThe review used 6–8 g citrulline malate 40–60 minutes before exercise. In seven studies it was taken once; in da Silva the supplement was also taken before repeat tests at 24, 48 and 72 hours.
Six weeks of resistance trainingIn trained men, 8 g L-citrulline or 12 g L-citrulline DL-malate daily was studied for 6 weeks alongside four training sessions per week; the control received placebo and the same training.
Single-dose comparison of formsIn trained men, 8 g L-citrulline, 12 g citrulline malate and placebo were compared 60 minutes before exercise; visits were approximately one week apart. Repetitions and soreness at 24, 48 and 72 hours were assessed.
Repeated sprint11 trained male sprinters took 8 g commercial citrulline malate between two 100 m runs; 80–90 minutes elapsed between runs. Control: 8 g microcrystalline cellulose.
How to read the regimensThese are regimens from studies, not universal doses for self-administration.

Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females ↗
Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Systematic Review and Meta-Analysis ↗
Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗
Acute effects of L-Citrulline vs. Citrulline malate supplementation on resistance training performance, muscle soreness, and blood biomarkers in resistance-trained men: a double-blind placebo-controlled counter-balanced trial ↗
Effects of Acute Citrulline Malate Supplementation on Repeated 100 m Sprint Performance in Trained Sprinters: A Randomized Crossover Study ↗

Forms

L-citrulline and citrulline malate are different forms; the mass of the mixture is not the mass of citrulline. Watermelon and multi-ingredient products are not a single pure substance.

Guidance for each goal

maximal strength2/4 LowRead moreCollapse
Confidence
2/4 LowChappell, Farney, Glenn and Hwang were pooled; for Hwang, whether the 4- or 8-week time point was used in the meta-analysis is not established. Aguiar’s journal table is unavailable; the thesis does not establish that it is identical. Upper and lower body are subgroups, not new studies. Chappell, Farney, Glenn and Hwang are named; the review is not a new trial, and 138 observations should not be counted as 138 unique participants. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 1, imprecision 1, publication bias 0; no upgrades. Low confidence (2) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

In pooled malate trials, an advantage in maximal strength was not established. Upper- and lower-body estimates are presented as subgroups.

Study findings. In pooled malate trials, an advantage in maximal strength was not established. Upper- and lower-body estimates are presented as subgroups.

Studied regimenChappell, Farney and Glenn: 8 g citrulline malate; Hwang: 2 g/day citrulline malate.oral citrulline malate
Duration and populationThree acute trials: a single dose 60 minutes before exercise; Hwang: an 8-week course, while the thesis table separately indicates 4 weeks; the time point selected for the meta-analysis is not established.Trained adults, 4 RCTs, 138 observations across conditions, not necessarily unique individuals

Comparison with placebo

hack squat 1RM3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateOver six weeks, an additional increase in hack-squat 1RM compared with placebo was not established, although all groups improved with training. Confidence is moderate: the groups were small, and the absence of a significant difference does not prove that the effects are equal.

An additional change in 1RM was not statistically established.

Study findings. An additional change in 1RM was not statistically established.

Studied regimen8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training
Duration and population6 weeks, 4 training sessions per week36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo

Comparison with placebo plus the same training

bench press 1RM3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateOver six weeks, an additional increase in bench-press 1RM compared with placebo was not established, although all groups improved with training. Confidence is moderate: the groups were small, and the absence of a significant difference does not prove that the effects are equal.

An additional change in 1RM was not statistically established.

Study findings. An additional change in 1RM was not statistically established.

Studied regimen8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training
Duration and population6 weeks, 4 training sessions per week36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo

Comparison with placebo plus the same training

Total repetitions to failure2/4 LowRead moreCollapse
Confidence
2/4 LowThe review reported a small average increase in repetitions after citrulline malate. Confidence is low: the size of the effect is imprecise, and an analysis of potentially missing studies weakens the result.

The review reported a small average increase in repetitions with citrulline malate.

Study findings. The review reported a small average increase in repetitions with citrulline malate.

Studied regimen6 g citrulline malate in da Silva and 8 g in the other seven studies; usually 60 minutes before exercise, Gonzalez 40 minutes.oral citrulline malate
Duration and populationA single pre-exercise dose in seven studies; da Silva: before exercise and repeat tests at 24, 48 and 72 hours according to Methods, although the abstract describes a single dose.8 studies, 137 participants, predominantly trained men and 26 women

Comparison with placebo

repetitions in five sets of squats at 70% 1RM3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateMeans and SDs are reported for five sets of squats under each condition; the overall condition test does not prove equality in every pairwise comparison. The registration shared with Bayat2025 does not establish that the participants were independent; I do not count two studies for this outcome. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No significant condition effect was established in this acute comparison.

Study findings. No significant condition effect was established in this acute comparison.

Studied regimen8 g L-citrulline or 12 g malate as a single doseoral L-citrulline or citrulline malate
Duration and population60 minutes before exercise; periods one week apart22 trained men aged 18–35 who completed the study, crossover RCT

Comparison with placebo

bench press repetitions3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateMeans and SDs for each condition are reported for five sets of bench presses; the overall condition test does not prove equality in every pairwise comparison. The registration shared with Bayat2025 does not establish that the participants were independent; I do not count two studies for this outcome. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No significant condition effect was established in this acute comparison.

Study findings. No significant condition effect was established in this acute comparison.

Studied regimen8 g free L-citrulline or 12 g malate as a single doseoral L-citrulline or citrulline malate
Duration and population60 minutes before exercisethe same 22 trained men

Comparison with placebo

repetitions to failure in three sets of hack squats2/4 LowRead moreCollapse
Confidence
2/4 LowAn advantage of either individual form in hack-squat repetitions was not confirmed. Confidence is low: the groups were small, and possible unblinding matters for a test to failure.

An advantage of an individual form over placebo for this outcome was not confirmed.

Study findings. An advantage of an individual form over placebo for this outcome was not confirmed.

Studied regimen8 g L-citrulline/day or 12 g malate/dayoral L-citrulline or L-citrulline DL-malate
Duration and population6 weeks36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo

Comparison with placebo; all groups train

leg extension repetitions2/4 LowRead moreCollapse
Confidence
2/4 LowAn advantage of either individual form in leg-extension repetitions was not confirmed. Confidence is low: the groups were small, and possible unblinding matters for a test to failure.

An advantage of an individual form over placebo for this outcome was not confirmed.

Study findings. An advantage of an individual form over placebo for this outcome was not confirmed.

Studied regimen8 g or 12 g/day respectivelyoral L-citrulline or L-citrulline DL-malate
Duration and population6 weeks36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo

Comparison with placebo; all groups train

total hack squat and leg extension repetitions2/4 LowRead moreCollapse
Confidence
2/4 LowThe overall test of changes in lower-body repetitions showed a difference, but the comparison of L-citrulline with placebo and the group × time interaction did not establish an advantage. Confidence is low because of the small groups and possible unblinding.

An advantage of an individual form over placebo for this outcome was not confirmed.

Study findings. An advantage of an individual form over placebo for this outcome was not confirmed.

Studied regimen8 g or 12 g/day respectivelyoral L-citrulline or L-citrulline DL-malate
Duration and population6 weeks36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo

Comparison with placebo; all groups train

Total repetitions to failure in six sets of bench press and incline press2/4 LowRead moreCollapse
Confidence
2/4 LowIn one small trial, both forms produced more upper-body repetitions than placebo. Confidence is low: the estimates are imprecise, and possible unblinding matters for tests to failure.

In one small RCT both forms increased repetitions relative to placebo.

Study findings. In one small RCT both forms increased repetitions relative to placebo.

Studied regimen8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training
Duration and population6 weeks, 4 training sessions per week36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo

Comparison with placebo plus the same training

Time to complete a fixed distance/task3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateA difference in task-completion time was not established. Confidence is moderate only for the pooled mix of forms and regimens: effects in either direction are possible, and the two CIs in the source disagree.

No difference in completion time was established.

Study findings. No difference in completion time was established.

Studied regimenMartínez-Sánchez: 500 ml juice with 3.45 g citrulline; Shanely: 980 ml purée with 1.47 g/day and about 4.39 g during the race; Stanelle: 6 g/day; Suzuki: 2.4 g/day L-citrulline.oral L-citrulline and watermelon products containing citrulline
Duration and populationMartínez-Sánchez: single dose 2 hours before; Shanely: 14 days; Stanelle: 7 days; Suzuki: 7 days plus a dose on day 8.Four crossover RCTs in healthy adults with varying fitness; 158 participants refer to all nine studies in the review.

Comparison with placebo/control

time to exhaustion3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateNo clear change in time to exhaustion was shown. Confidence is moderate only for the pooled mix of forms and regimens: the interval permits effects in either direction.

The pooled trials showed no clear change in time to exhaustion; the result does not apply to just one form.

Study findings. The pooled trials showed no clear change in time to exhaustion; the result does not apply to just one form.

Studied regimenBailey 2015: 6 g/day L-citrulline; Bailey 2016: 300 ml watermelon concentrate, about 3.4 g/day citrulline; Cutrufello: 6 g L-citrulline; Gills: 8 g malate; Hickner: 3 g or 9 g L-citrulline.various oral citrulline sources, including foods
Duration and populationBailey: 7 and 16 days; Cutrufello and Gills: single doses 1–2 hours and 60 minutes before, respectively; Hickner: 3 g 3 hours before or 9 g 24 hours before.Five crossover RCTs in healthy physically active adults; 158 participants refer to all nine studies in the review.

Comparison with control

Subjective soreness2/4 LowRead moreCollapse
Confidence
2/4 LowAt 24 hours, the pooled estimate showed less soreness. Confidence is low for the studied mix of products: results varied greatly, and the wide interval does not pin down the size of the benefit.

In seven comparisons of citrulline-containing interventions, soreness at 24 hours was lower; the pooled effect size was −0.99, with substantial variation between studies.

Study findings. In seven comparisons of citrulline-containing interventions, soreness at 24 hours was lower; the pooled effect size was −0.99, with substantial variation between studies.

Studied regimen6–8 g citrulline malate or watermelon products containing 3.3–6 g citrulline; the subset composition is specified by study.Citrulline malate and watermelon products containing citrulline; the composition of the specific subset is retained in the protocols.
Duration and populationSingle dose 60–120 minutes before exercise in most trials; da Silva: before exercise and tests at 24, 48, 72 hours according to Methods; soreness assessed at 24 hours.Healthy adults, 7 comparisons of soreness at 24 hours after exercise; sample sizes total 131, and the number of unique people across publications is unconfirmed. The whole review includes 13 studies and 206 participants.

Comparison with placebo; in Tarazona-Díaz, unfortified watermelon juice with 1.17 g citrulline.

Subjective soreness2/4 LowRead moreCollapse
Confidence
2/4 LowAt 48 hours, the main analysis did not establish a difference; after one study was excluded, the estimate changed, but variability remained high. Confidence is low for the studied mix of products.

The primary analysis found no difference at 48 hours.

Study findings. The primary analysis found no difference at 48 hours.

Studied regimen6–8 g citrulline malate or watermelon juice containing 3.3 or 3.45 g citrulline; the subset composition is specified by study.Citrulline malate and watermelon products containing citrulline; the composition of the specific subset is retained in the protocols.
Duration and populationSingle dose 60–120 minutes before exercise in most trials; da Silva: before exercise and tests at 24, 48, 72 hours according to Methods; soreness assessed at 48 hours.Healthy adults, 6 comparisons of soreness at 48 hours after exercise; sample sizes total 124, and the number of unique people across publications is unconfirmed. The whole review includes 13 studies and 206 participants.

Comparison with placebo

Subjective soreness2/4 LowRead moreCollapse
Confidence
2/4 LowFour comparisons; the sum of the sample sizes, 64, does not mean unique individuals. The CI of −1.98…1.16 permits substantially different effects; repeated time points are not separate trials. Repeated time points and reviews are not independent replications; the mixing of matrices is included in the exact scope of the conclusion. Starting level 4; downgrades: risk of bias 0, inconsistency 1, indirectness 0, imprecision 1, publication bias 0; no upgrades. Low confidence (2) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No difference was found at 72 hours.

Study findings. No difference was found at 72 hours.

Studied regimen6–8 g citrulline malate or watermelon juice containing 3.45 g citrulline; the subset composition is specified by study.Citrulline malate and watermelon products containing citrulline; the composition of the specific subset is retained in the protocols.
Duration and populationSingle dose 60–120 minutes before exercise in most trials; da Silva: before exercise and tests at 24, 48, 72 hours according to Methods; soreness assessed at 72 hours.Healthy adults, 4 comparisons of soreness at 72 hours after exercise; sample sizes total 64, and the number of unique people across publications is unconfirmed. The whole review includes 13 studies and 206 participants.

Comparison with placebo

Soreness at 24 hours3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateIn the original study, quadriceps and pectoral-muscle VAS scores were measured at 24 hours; the overall analysis of conditions and interactions is not a separate pairwise effect at this time point. The registration shared with Bayat2025 does not establish that the participants were independent; I do not count two studies for this outcome. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No significant differences in soreness were reported in this comparison.

Study findings. No significant differences in soreness were reported in this comparison.

Studied regimen8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before
Duration and populationOne dose per visit, approximately one week apart24 trained men aged 18–35 enrolled, 22 completed the crossover comparison

Comparison with placebo, 3 conditions in random order

Soreness at 48 hours3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateIn the original study, quadriceps and pectoral-muscle VAS scores were measured at 48 hours; the overall analysis of conditions and interactions is not a separate pairwise effect at this time point. The registration shared with Bayat2025 does not establish that the participants were independent; I do not count two studies for this outcome. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No significant differences in soreness were reported in this comparison.

Study findings. No significant differences in soreness were reported in this comparison.

Studied regimen8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before
Duration and populationOne dose per visit, approximately one week apart24 trained men aged 18–35 enrolled, 22 completed the crossover comparison

Comparison with placebo, 3 conditions in random order

Soreness at 72 hours3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateIn the original study, quadriceps and pectoral-muscle VAS scores were measured at 72 hours; the overall analysis of conditions and interactions is not a separate pairwise effect at this time point. The registration shared with Bayat2025 does not establish that the participants were independent; I do not count two studies for this outcome. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

No significant differences in soreness were reported in this comparison.

Study findings. No significant differences in soreness were reported in this comparison.

Studied regimen8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before8 g L-citrulline or 12 g citrulline malate (claimed 2:1), 60 min before
Duration and populationOne dose per visit, approximately one week apart24 trained men aged 18–35 enrolled, 22 completed the crossover comparison

Comparison with placebo, 3 conditions in random order

Borg 6–20 before the second sprint3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateBorg 6–20 was measured immediately before the second sprint, not after it; the result concerns the same 11 sprinters as both time outcomes. The threshold for a practically meaningful difference is unknown; the statistical result does not prove practical importance. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

Before the second run, participants rated exertion as less strenuous after malate.

Study findings. Before the second run, participants rated exertion as less strenuous after malate.

Studied regimen8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs
Duration and populationSingle dose; 100 m twice, 80–90 minutes between runs11 trained male sprinters, randomized double-blind crossover trial

Comparison with 8 g microcrystalline cellulose

Total lower-body RPE2/4 LowRead moreCollapse
Confidence
2/4 LowTotal lower-body RPE decreased in all groups; the interaction proves neither the absence of an effect nor equality of the individual forms. Bayat2025 and Bayat2026 report the same registration number, and participant overlap is not established; for this outcome, these are not two independent trials. Starting level 4; downgrades: risk of bias 1, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Low confidence (2) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of leg exercise.

Study findings. Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of leg exercise.

Studied regimen8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training
Duration and population6 weeks, 4 training sessions per week36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo

Comparison with placebo plus the same training

Total upper-body RPE2/4 LowRead moreCollapse
Confidence
2/4 LowTotal upper-body RPE decreased in all groups; the interaction proves neither the absence of an effect nor equality of the individual forms. Bayat2025 and Bayat2026 report the same registration number, and participant overlap is not established; for this outcome, these are not two independent trials. Starting level 4; downgrades: risk of bias 1, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Low confidence (2) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of upper-body exercise.

Study findings. Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of upper-body exercise.

Studied regimen8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training
Duration and population6 weeks, 4 training sessions per week36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo

Comparison with placebo plus the same training

Wind-adjusted difference between second and first run times3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateThe comparison of wind-adjusted changes differs from a comparison of the time in an individual sprint; external conditions may have had an influence, although wind was measured. The stated 8 g refers to the product, not pure citrulline. The threshold for a practically meaningful difference is unknown; the statistical result does not prove practical importance. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

The difference in changes favored malate in this protocol.

Study findings. The difference in changes favored malate in this protocol.

Studied regimen8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs
Duration and populationSingle dose; 100 m twice, 80–90 minutes between runs11 trained male sprinters, randomized double-blind crossover trial

Comparison with 8 g microcrystalline cellulose

Unadjusted difference between second and first run times3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateThe comparison of changes in raw time shows a difference; the individual outcomes for each sprint showed no significant difference. Weather conditions remain a source of variation; 8 g is the mass of the product. The threshold for a practically meaningful difference is unknown; the statistical result does not prove practical importance. Starting level 4; downgrades: risk of bias 0, inconsistency 0, indirectness 0, imprecision 1, publication bias 0; no upgrades. Moderate confidence (3) applies only to the stated comparison, does not establish practical significance and is not clinical approval.

Changes in raw time between runs differed in this protocol.

Study findings. Changes in raw time between runs differed in this protocol.

Studied regimen8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs8 g commercial citrulline malate with a stated 2:1 ratio between the first and second runs
Duration and populationSingle dose; 100 m twice, 80–90 minutes between runs11 trained male sprinters, randomized double-blind crossover trial

Comparison with 8 g microcrystalline cellulose

Safety and limitations

Preeclampsia is a pregnancy complication involving elevated blood pressure. If you have preeclampsia, discuss taking citrulline with your doctor: in a study of such women, systolic pressure and liver measures were higher than with placebo. In an RCT of 115 women with preeclampsia (58 citrulline, 57 placebo), systolic pressure on the day of delivery was higher with citrulline (p=0.015); these data concern this group specifically, not uncomplicated pregnancy. In an RCT of 115 women with preeclampsia (58 citrulline, 57 placebo), no difference in diastolic pressure was found on the day of delivery. In an RCT of 115 women with preeclampsia (58 citrulline, 57 placebo), ALT on the day of delivery was 65.1 versus 33.2 U/L with placebo. In an RCT of 115 women with preeclampsia (58 citrulline, 57 placebo), AST on the day of delivery was 70.4 versus 33.7 U/L with placebo. A clinical case followed a product containing arginine α-ketoglutarate, L-citrulline, L-tyrosine, creatine malate and beetroot. The causal contribution of any individual component and frequency were not assessed. In a study of 8 g malate, 6/41 reported discomfort; the comparable placebo frequency was not determined. In a 10-day crossover study of 100 mg/kg/day L-citrulline, one person reported cramps on citrulline, another diarrhea on placebo; frequency and causality cannot be assessed. An uncontrolled study of sequential doses of 6, 12, 18, 24 g/day for 28 days each in 23 men who completed it does not establish a universally safe dose. A reported case of liver injury after a multi-ingredient product does not prove causation by citrulline alone. There are insufficient data to claim safety of self-administration during breastfeeding or by healthy children; brief supervised enteral use in preterm infants cannot be extrapolated to sports supplements. Malate ratios and actual content vary: in a check of five 2:1 samples, measured ratios were 1.11:1–1.92:1; this is not a study of the entire market. No listed research dose is universally optimal or safe.

Oral citrulline supplementation in pregnancies with preeclampsia: a multicenter, randomized, double-blind clinical trial ↗ · Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE) ↗ · A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis-Can We Draw a Line? ↗ · Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness ↗ · Ergogenic effects of a 10-day L-citrulline supplementation on time to exhaustion and cardiorespiratory and metabolic responses in healthy individuals: a double-blind, randomised, placebo-controlled crossover trial ↗ · Subchronic tolerance trials of graded oral supplementation with ornithine hydrochloride or citrulline in healthy adults ↗ · Enteral L-citrulline supplementation in preterm infants is safe and effective in increasing plasma arginine and citrulline levels-a pilot randomized trial ↗ · Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females ↗ · Pre-eclampsia - NHS ↗

Interactions

WithEffectActionSource
Antihypertensive drugs, nitrates and PDE-5 inhibitorsPossible enhancement of vascular effects is hypothetical; a controlled quantitative assessment of a specific interaction has not been established.If you take these medications, discuss a citrulline supplement with your treating clinician before starting it.Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study ↗

Food sources

Food content depends on the product and the part of the fruit; the amount of pure citrulline cannot be equated with the mass of citrulline malate.

Watermelon contains L-citrulline; content differs between flesh and rind, and in the rind also between cultivars. Food is not a dose equivalent to 6–12 g of pure citrulline or malate from training studies.

Potential role of L-citrulline in regulating exercise performance and muscle protein metabolism ↗

Watermelon L-citrulline is present in watermelon flesh and rind; rind content varies by cultivar.

Potential role of L-citrulline in regulating exercise performance and muscle protein metabolism ↗

Other cucurbits Citrulline is also found in cucumber, pumpkin, melon and bitter melon.

Potential role of L-citrulline in regulating exercise performance and muscle protein metabolism ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Effects of Citrulline Malate Supplementation on Muscle Strength in Resistance-Trained Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗systematic review and meta-analysis of randomized trialsmaximal strengthTrained adults, 4 RCTs, 138 observations across conditions, not necessarily unique individualsoral citrulline malate; Chappell, Farney and Glenn: 8 g citrulline malate; Hwang: 2 g/day citrulline malate.; Three acute trials: a single dose 60 minutes before; Hwang: an 8-week course, while the thesis table separately indicates 4 weeks; the time point selected for the meta-analysis is not established.; comparison: placeboIn pooled malate trials, an advantage in maximal strength was not established. Upper- and lower-body estimates are presented as subgroups.
Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗randomized trialhack squat 1RM: hack squat 1RM bench press 1RM: bench press 1RM repetitions to failure in three sets of hack squats: repetitions to failure in three sets of hack squats leg extension repetitions: leg extension repetitions total hack squat and leg extension repetitions: total hack squat and leg extension repetitions Total repetitions to failure in six sets of bench press and incline press: Total repetitions to failure in six sets of bench press and incline press Total lower-body RPE: Total lower-body RPE Total upper-body RPE: Total upper-body RPEhack squat 1RM: 36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo bench press 1RM: 36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo repetitions to failure in three sets of hack squats: 36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo leg extension repetitions: 36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo total hack squat and leg extension repetitions: 36 trained men randomized; 33 completed: 11 L-citrulline, 12 malate and 10 placebo Total repetitions to failure in six sets of bench press and incline press: 36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo Total lower-body RPE: 36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebo Total upper-body RPE: 36 trained men randomized, 33 completed: 11 L-citrulline, 12 malate, 10 placebohack squat 1RM: 8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training; 6 weeks, 4 training sessions per week; comparison: placebo plus the same training bench press 1RM: 8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training; 6 weeks, 4 training sessions per week; comparison: placebo plus the same training repetitions to failure in three sets of hack squats: oral L-citrulline or L-citrulline DL-malate; 8 g L-citrulline/day or 12 g malate/day; 6 weeks; comparison: placebo; all groups train leg extension repetitions: oral L-citrulline or L-citrulline DL-malate; 8 g or 12 g/day respectively; 6 weeks; comparison: placebo; all groups train total hack squat and leg extension repetitions: oral L-citrulline or L-citrulline DL-malate; 8 g or 12 g/day respectively; 6 weeks; comparison: placebo; all groups train Total repetitions to failure in six sets of bench press and incline press: 8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training; 6 weeks, 4 training sessions per week; comparison: placebo plus the same training Total lower-body RPE: 8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training; 6 weeks, 4 training sessions per week; comparison: placebo plus the same training Total upper-body RPE: 8 g/day L-citrulline (7.96 g measured) or 12 g/day L-citrulline DL-malate (8.4 g L-citrulline measured), plus resistance training; 6 weeks, 4 training sessions per week; comparison: placebo plus the same traininghack squat 1RM: An additional change in 1RM was not statistically established. bench press 1RM: An additional change in 1RM was not statistically established. repetitions to failure in three sets of hack squats: An advantage of an individual form over placebo for this outcome was not confirmed. leg extension repetitions: An advantage of an individual form over placebo for this outcome was not confirmed. total hack squat and leg extension repetitions: An advantage of an individual form over placebo for this outcome was not confirmed. Total repetitions to failure in six sets of bench press and incline press: In one small RCT both forms increased repetitions relative to placebo. Total lower-body RPE: Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of leg exercise. Total upper-body RPE: Over 6 weeks the supplements did not produce an additional reduction in perceived difficulty of upper-body exercise.

Sources

Sources
  1. Effects of Citrulline Malate Supplementation on Muscle Strength in Resistance-Trained Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
  2. Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial ↗
  3. Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Systematic Review and Meta-Analysis ↗
  4. Acute effects of L-Citrulline vs. Citrulline malate supplementation on resistance training performance, muscle soreness, and blood biomarkers in resistance-trained men: a double-blind placebo-controlled counter-balanced trial ↗
  5. Effects of citrulline on endurance performance in young healthy adults: a systematic review and meta-analysis ↗
  6. Effect of citrulline on post-exercise rating of perceived exertion, muscle soreness, and blood lactate levels: A systematic review and meta-analysis ↗
  7. Effects of Acute Citrulline Malate Supplementation on Repeated 100 m Sprint Performance in Trained Sprinters: A Randomized Crossover Study ↗
  8. Oral citrulline supplementation in pregnancies with preeclampsia: a multicenter, randomized, double-blind clinical trial ↗
  9. Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE) ↗
  10. A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis-Can We Draw a Line? ↗
  11. Dietary Supplements for Exercise and Athletic Performance: Health Professional Fact Sheet ↗
  12. Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness ↗
  13. Ergogenic effects of a 10-day L-citrulline supplementation on time to exhaustion and cardiorespiratory and metabolic responses in healthy individuals: a double-blind, randomised, placebo-controlled crossover trial ↗
  14. Subchronic tolerance trials of graded oral supplementation with ornithine hydrochloride or citrulline in healthy adults ↗
  15. Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study ↗
  16. Enteral L-citrulline supplementation in preterm infants is safe and effective in increasing plasma arginine and citrulline levels-a pilot randomized trial ↗
  17. Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females ↗
  18. Potential role of L-citrulline in regulating exercise performance and muscle protein metabolism ↗
  19. Pre-eclampsia - NHS ↗